AT343653B - Verfahren zur herstellung von neuen 3-amino-indazolcarbonsaure- derivaten - Google Patents

Verfahren zur herstellung von neuen 3-amino-indazolcarbonsaure- derivaten

Info

Publication number
AT343653B
AT343653B AT939775A AT939775A AT343653B AT 343653 B AT343653 B AT 343653B AT 939775 A AT939775 A AT 939775A AT 939775 A AT939775 A AT 939775A AT 343653 B AT343653 B AT 343653B
Authority
AT
Austria
Prior art keywords
indazol
amino
acid derivatives
carbon acid
producing new
Prior art date
Application number
AT939775A
Other languages
English (en)
Other versions
ATA939775A (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ATA939775A publication Critical patent/ATA939775A/de
Application granted granted Critical
Publication of AT343653B publication Critical patent/AT343653B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT939775A 1974-12-13 1975-12-11 Verfahren zur herstellung von neuen 3-amino-indazolcarbonsaure- derivaten AT343653B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2458965A DE2458965C3 (de) 1974-12-13 1974-12-13 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
ATA939775A ATA939775A (de) 1977-10-15
AT343653B true AT343653B (de) 1978-06-12

Family

ID=5933305

Family Applications (1)

Application Number Title Priority Date Filing Date
AT939775A AT343653B (de) 1974-12-13 1975-12-11 Verfahren zur herstellung von neuen 3-amino-indazolcarbonsaure- derivaten

Country Status (27)

Country Link
US (1) US4051252A (de)
JP (1) JPS5182266A (de)
AT (1) AT343653B (de)
BE (1) BE836528A (de)
CA (1) CA1059523A (de)
CH (1) CH622250A5 (de)
CS (1) CS189731B2 (de)
DD (1) DD125484A5 (de)
DE (1) DE2458965C3 (de)
DK (1) DK137082C (de)
ES (1) ES443429A1 (de)
FI (1) FI753493A7 (de)
FR (1) FR2293928A1 (de)
GB (1) GB1490306A (de)
HK (1) HK52580A (de)
HU (1) HU173557B (de)
IE (1) IE42208B1 (de)
IL (1) IL48642A (de)
KE (1) KE3078A (de)
LU (1) LU73993A1 (de)
NL (1) NL7514521A (de)
NO (1) NO145382C (de)
PL (1) PL99858B1 (de)
SE (1) SE419645B (de)
SU (1) SU604487A3 (de)
YU (1) YU315275A (de)
ZA (1) ZA757777B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431657A (en) * 1982-05-24 1984-02-14 Ayerst, Mckenna & Harrison Inc. Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
KR20010086657A (ko) * 2000-03-02 2001-09-15 성재갑 아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
ATE346064T1 (de) 2000-09-15 2006-12-15 Vertex Pharma Pyrazolverbindungen als protein-kinasehemmer
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
ZA200301701B (en) * 2000-09-15 2004-03-01 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors.
SI1318997T1 (sl) * 2000-09-15 2006-12-31 Vertex Pharma Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
WO2002068415A1 (en) 2000-12-21 2002-09-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
KR100406634B1 (ko) * 2001-03-12 2003-11-20 주식회사 엘지생명과학 3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
PL368347A1 (en) 2001-09-26 2005-03-21 Pharmacia Italia S.P.A. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
RU2004126671A (ru) * 2002-02-06 2005-04-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US20040009981A1 (en) 2002-03-15 2004-01-15 David Bebbington Compositions useful as inhibitors of protein kinases
WO2003097610A1 (en) 2002-05-17 2003-11-27 Pharmacia Italia S.P.A. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
JP4733388B2 (ja) 2002-08-02 2011-07-27 バーテックス ファーマシューティカルズ インコーポレイテッド Ｇｓｋ−３のインヒビターとして有用なピラゾール組成物
CA2502429A1 (en) * 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
US7601718B2 (en) 2003-02-06 2009-10-13 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
JP2007513184A (ja) * 2003-12-04 2007-05-24 バーテックス　ファーマシューティカルズ　インコーポレイテッド プロテインキナーゼのインヒビターとして有用なキノキサリン
DE102004005172A1 (de) 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
EP1917259B1 (de) 2005-08-18 2012-01-25 Vertex Pharmaceuticals Incorporated Pyrazinkinaseinhibitoren
WO2007056163A2 (en) 2005-11-03 2007-05-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
US7847104B2 (en) * 2006-04-14 2010-12-07 Abbott Laboratories Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors
NZ576750A (en) 2006-11-02 2012-01-12 Vertex Pharma Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
AU2007333650A1 (en) 2006-12-19 2008-06-26 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
MX2009009592A (es) 2007-03-09 2009-11-10 Vertex Pharma Aminopiridinas utiles como inhibidores de proteinas cinasas.
WO2008112651A2 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
WO2008112642A1 (en) 2007-03-09 2008-09-18 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as inhibitors of protein kinases
AU2008240313A1 (en) 2007-04-13 2008-10-23 Aj Park Aminopyrimidines useful as kinase inhibitors
WO2008137622A2 (en) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
CN101801959A (zh) 2007-05-02 2010-08-11 沃泰克斯药物股份有限公司 可用作激酶抑制剂的氨基嘧啶类化合物
CN101679378A (zh) * 2007-05-02 2010-03-24 沃泰克斯药物股份有限公司 用作激酶抑制剂的噻唑和吡唑
CN101687852A (zh) * 2007-05-24 2010-03-31 沃泰克斯药物股份有限公司 可用作激酶抑制剂的噻唑类和吡唑类化合物
JP5553751B2 (ja) 2007-07-31 2014-07-16 バーテックス ファーマシューティカルズ インコーポレイテッド ５−フルオロ−１Ｈ−ピラゾロ［３，４−ｂ］ピリジン−３−アミンおよびその誘導体を調製するためのプロセス
WO2010027921A1 (en) * 2008-09-03 2010-03-11 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical formulations comprising the same
DE102009004245A1 (de) 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
HRP20180543T1 (hr) 2012-07-24 2018-06-29 Bial-Portela & Ca, S.A. Spojevi uree i njihova upotreba kao inhibitora enzima
JP2015528013A (ja) * 2012-07-27 2015-09-24 ビアル−ポルテラ エ コンパニア，ソシエダッド アノニマ 置換ウレア化合物の合成方法
CA2918993C (en) 2013-07-24 2021-08-24 Bial - Portela & Ca, S.A. Imidazolecarboxamides and their use as faah inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133081A (en) * 1964-05-12 J-aminoindazole derivatives
CH397698A (de) * 1961-09-08 1965-08-31 Siegfried Ag Verfahren zur Herstellung neuer 1-Carbamyl-indazole
US3277100A (en) * 1963-05-31 1966-10-04 Du Pont Novel substituted pyrazoles
NL6707299A (de) * 1966-07-16 1968-01-17
DE1770649A1 (de) * 1968-06-15 1971-11-11 Bayer Ag Substituierte 3-Amino-indazole

Also Published As

Publication number Publication date
FI753493A7 (de) 1976-06-14
CS189731B2 (en) 1979-04-30
SE419645B (sv) 1981-08-17
US4051252A (en) 1977-09-27
BE836528A (fr) 1976-06-11
SE7513990L (sv) 1976-06-14
PL99858B1 (pl) 1978-08-31
ES443429A1 (es) 1977-04-16
FR2293928B1 (de) 1979-09-21
DK137082B (da) 1978-01-16
CH622250A5 (de) 1981-03-31
NO145382B (no) 1981-11-30
NO145382C (no) 1982-03-10
IL48642A0 (en) 1976-02-29
IL48642A (en) 1979-12-30
YU315275A (en) 1982-02-28
DD125484A5 (de) 1977-04-20
DE2458965B2 (de) 1979-02-22
ZA757777B (en) 1976-11-24
DK137082C (da) 1978-06-19
DE2458965C3 (de) 1979-10-11
LU73993A1 (de) 1976-11-11
JPS5182266A (en) 1976-07-19
DK567275A (da) 1976-06-14
SU604487A3 (ru) 1978-04-25
IE42208B1 (en) 1980-06-18
HU173557B (hu) 1979-06-28
DE2458965A1 (de) 1976-06-16
HK52580A (en) 1980-09-26
CA1059523A (en) 1979-07-31
NO754024L (de) 1976-06-15
AU8717075A (en) 1977-06-09
IE42208L (en) 1976-06-13
ATA939775A (de) 1977-10-15
KE3078A (en) 1980-10-03
NL7514521A (nl) 1976-06-15
GB1490306A (en) 1977-11-02
FR2293928A1 (fr) 1976-07-09

Similar Documents

Publication Publication Date Title
AT343653B (de) Verfahren zur herstellung von neuen 3-amino-indazolcarbonsaure- derivaten
AT348693B (de) Verfahren zur herstellung von neuen decapeptidamidderivaten
AT344890B (de) Verfahren zur herstellung von neuen 6-thiatetracyclinen
AT344333B (de) Verfahren zur herstellung von neuen 8-thiomethylergolinen
AT336589B (de) Verfahren zur herstellung von neuen biphenylderivaten
AT348540B (de) Verfahren zur herstellung von neuen substituierten phenylguanidinen
AT350529B (de) Verfahren zur herstellung von neuen acylaminophenylalkylaminen
AT350064B (de) Verfahren zur herstellung von neuen thienothiazinderivaten
ATA251375A (de) Verfahren zur herstellung von neuen prostaglandin-analoen
AT345815B (de) Verfahren zur herstellung von neuen thiadiazolylimidazolidinonderivaten
AT343675B (de) Verfahren zur herstellung von neuen biguaniden
ATA428075A (de) Verfahren zur herstellung von neuen 1-aethyl-3a-metasubstituiertes-phenyl-decahydroisochinolinen
AT346311B (de) Verfahren zur herstellung von neuen polyenverbindungen
AT337672B (de) Verfahren zur herstellung von neuen abietamidderivaten
AT342590B (de) Verfahren zur herstellung von neuen 2-amino-6-dialkylaminodihydropyridinen
AT337897B (de) Verfahren zur herstellung von neuen acylderivaten
AT341539B (de) Verfahren zur herstellung von neuen 3-amino-2beta-thiohydrazoazetidinonen
AT342046B (de) Verfahren zur herstellung von neuen n-benzylaminooxazolinen
AT349160B (de) Verfahren zur herstellung von neuen bufatrienolidrhamnosidaethern
AT365170B (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten
AT348697B (de) Verfahren zur herstellung von neuen d- homosteroiden
AT343144B (de) Verfahren zur herstellung von neuen glucosederivaten
AT349161B (de) Verfahren zur herstellung von neuen quaternaeren salzen
AT341489B (de) Verfahren zur herstellung von neuen acetoximderivaten
AT343108B (de) Verfahren zur herstellung von neuen nitrofurylverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee